Non Small Cell Lung Cancer With An Egfr Driver Mutation clinical trials

Explore recruiting non small cell lung cancer with an egfr driver mutation clinical trials.

Also recruiting in Europe

Non Small Cell Lung Cancer With An Egfr Driver Mutation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Modified osimertinib dosing, with or without cobicistat as a pharmacokinetic booster, to improve cost-effectiveness of advanced Non-Small Cell Lung Cancer treatment - OSIBOOST 2

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Non Small Cell Lung Cancer With An Egfr Driver Mutation trials by city

Non Small Cell Lung Cancer With An Egfr Driver Mutation in Toronto Non Small Cell Lung Cancer With An Egfr Driver Mutation in Vancouver Non Small Cell Lung Cancer With An Egfr Driver Mutation in Montreal Non Small Cell Lung Cancer With An Egfr Driver Mutation in Calgary Non Small Cell Lung Cancer With An Egfr Driver Mutation in Edmonton Non Small Cell Lung Cancer With An Egfr Driver Mutation in Ottawa Non Small Cell Lung Cancer With An Egfr Driver Mutation in Winnipeg Non Small Cell Lung Cancer With An Egfr Driver Mutation in Quebec City Non Small Cell Lung Cancer With An Egfr Driver Mutation in Hamilton Non Small Cell Lung Cancer With An Egfr Driver Mutation in Kitchener Non Small Cell Lung Cancer With An Egfr Driver Mutation in London Non Small Cell Lung Cancer With An Egfr Driver Mutation in Halifax Non Small Cell Lung Cancer With An Egfr Driver Mutation in New York Non Small Cell Lung Cancer With An Egfr Driver Mutation in Los Angeles Non Small Cell Lung Cancer With An Egfr Driver Mutation in Chicago Non Small Cell Lung Cancer With An Egfr Driver Mutation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease